购物车
您的购物车当前为空
别名 FP-025, FP025, AVX001, AKH-217, AKH217
AVX-001, a cytosolic phospholipase A2 (cPLA2) inhibitor, is used potentially for the treatment of psoriasis.

AVX-001, a cytosolic phospholipase A2 (cPLA2) inhibitor, is used potentially for the treatment of psoriasis.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 11,700 | 6-8周 | |
| 50 mg | ¥ 15,300 | 6-8周 | |
| 100 mg | ¥ 19,500 | 6-8周 |
| 产品描述 | AVX-001, a cytosolic phospholipase A2 (cPLA2) inhibitor, is used potentially for the treatment of psoriasis. |
| 别名 | FP-025, FP025, AVX001, AKH-217, AKH217 |
| 分子量 | 386.51 |
| 分子式 | C21H29F3OS |
| CAS No. | 300553-18-8 |
| Smiles | C(\CSCC(C(F)(F)F)=O)=C/CC/C=C\C/C=C\C/C=C\C/C=C\CC |
| 密度 | 1.042 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多